Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.
paper
Cited
Public
- Authors
- Hoffman, Jessica L; Faccidomo, Sara; Kim, Michelle; Taylor, Seth M; Agoglia, Abigail E; May, Ashley M; Smith, Evan N; Wong, L C; Hodge, Clyde W
- Year
- 2019
- Journal
- International review of neurobiology
- PMID
- 31733664
- DOI
- 10.1016/bs.irn.2019.10.017
- PMCID
- PMC6939615
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that represents the most common cause of dementia in the United States. Although the link between alcohol use and AD has been studied, preclinical research has potential to elucidate neurobiological mechanisms that underlie this interaction. This study was designed to test the hypothesis that nondependent alcohol drinking exacerbates the onset and magnitude of AD-like neural and behavioral pathology. We first evaluated the impact of voluntary 24-h, two-bottle choice home-cage alcohol drinking on the prefrontal cortex and amygdala neuroproteome in C57BL/6J mice and found a striking association between alcohol drinking and AD-like pathology. Bioinformatics identified the AD-associated proteins MAPT (Tau), amyloid beta precursor protein (APP), and presenilin-1 (PSEN-1) as the main modulators of alcohol-sensitive protein networks that included AD-related proteins that regulate energy metabolism (ATP5D, HK1, AK1, PGAM1, CKB), cytoskeletal development (BASP1, CAP1, DPYSL2 [CRMP2], ALDOA, TUBA1A, CFL2, ACTG1), cellular/oxidative stress (HSPA5, HSPA8, ENO1, ENO2), and DNA regulation (PURA, YWHAZ). To address the impact of alcohol drinking on AD, studies were conducted using 3xTg-AD mice that express human MAPT, APP, and PSEN-1 transgenes and develop AD-like brain and behavioral pathology. 3xTg-AD and wild-type mice consumed alcohol or saccharin for 4 months. Behavioral tests were administered during a 1-month alcohol-free period. Alcohol intake induced AD-like behavioral pathologies in 3xTg-AD mice including impaired spatial memory in the Morris Water Maze, diminished sensorimotor gating as measured by prepulse inhibition, and exacerbated conditioned fear. Multiplex immunoassay conducted on brain lysates showed that alcohol drinking upregulated primary markers of AD pathology in 3xTg-AD mice: Aβ 42/40 ratio in the lateral entorhinal and prefrontal cortex and total Tau expression in the lateral entorhinal cortex, medial prefrontal cortex, and amygdala at 1-month post alcohol exposure. Immunocytochemistry showed that alcohol use upregulated expression of pTau (Ser199/Ser202) in the hippocampus, which is consistent with late-stage AD. According to the NIA-AA Research Framework, these results suggest that alcohol use is associated with Alzheimer's pathology. Results also showed that alcohol use was associated with a general reduction in Akt/mTOR signaling via several phosphoproteins (IR, IRS1, IGF1R, PTEN, ERK, mTOR, p70S6K, RPS6) in multiple brain regions including hippocampus and entorhinal cortex. Dysregulation of Akt/mTOR phosphoproteins suggests alcohol may target this pathway in AD progression. These results suggest that nondependent alcohol drinking increases the onset and magnitude of AD-like neural and behavioral pathology in 3xTg-AD mice.
Bioinformatic analysis of alcohol-sensitive protein networks in PFC and amygdala identified major mechanisms of AD (MAPT, APP, and PSEN1) as the statistically most likely upstream regulators. (A) Illustration of mouse home-cage drinking method and sample brain regions showing anatomical location of tissue punches. (B) Representative 2D-DIGE gels from each experiment. (C) Results of IPA Upstream Regulator Analysis that identified Alzheimer’s disease mechanisms as top regulators of alcohol-sensitive protein networks. (D) Alcohol-sensitive proteins detected in each brain region that are known to be downstream of MAPT, APP, and PSEN1. P values indicate significant overlap between AD regulator protein and alcohol-sensitive Alzheimer’s-linked molecules. Arrows indicate increase () or decrease () in expression after alcohol drinking. Data are shown as fold change representing the mean of four replicate gels. Proteins were included only if significantly changed in all four gels.
(A) Alzheimer’s disease progression showing mouse brain regional involvement and clinical symptoms as a function severity. (B) Graphic representation of the overall hypothesis of the present study: alcohol use (red line) exacerbates the onset (leftward time-dependent shift in age of onset) and magnitude (upward shift in degree) of AD-like pathology (black line).
Experimental timeline. Mice drank solutions (alcohol or saccharin) starting at 3 months of age for 4 months. Behavioral testing occurred after experimental solutions were removed. Behavioral testing occurred in the following sequence with a minimum of 1 day in between each test: Open field locomotion, rotarod, Morris Water Maze, prepulse inhibition, fear conditioning. Brains were collected at 8 months of age, 10 days after the final behavioral test.
No differences in alcohol or saccharin intake or motor function in 3xTg-AD mice as compared to WT controls. (A) Average alcohol intake (g/kg) and preference (% total fluid) from the 4-month access period plotted as a function of genotype. (B) Average saccharin intake (mL) and preference (% total fluid) plotted as a function of genotype. (C) Average body weight (g) of WT and 3xTg-AD mice at 10 weeks of age (male and female combined). (D) Spontaneous locomotor behavior and habituation to an unfamiliar environment. Mice were placed in locomotor activity chambers, and distance traveled was measured during a single session. (E) Rotarod performance by 3xTg-AD and WT mice expressed as average latency to fall (s) over three trials. Data are shown as mean SEM. No statistically significant differences were detected between genotypes or alcohol/saccharin condition.
Alcohol drinking-induced behavioral deficits in 3xTg-AD mice. (A, left) Average escape latency (s) plotted as a function of trial during Morris Water Maze acquisition. * indicates significant main effect between genotypes over all trials. (A, right) Percentage of time (s) spent in the quadrant of the Morris Water Maze that previously contained the escape platform. * indicates significant difference between alcohol vs saccharin exposed 3xTg-AD mice, P < 0.05. (B) Average prepulse inhibition (%) plotted as a function of stimulus intensity (dB). * indicates statistically significant main effect between 3xTg-AD mice that consumed alcohol vs saccharin. (C, left) Cued fear response plotted as average freezing (% control seconds) as a function of genotype and alcohol intake condition. * indicates significant difference between 3xTg-AD mice that consumed alcohol vs saccharin, P < 0.05. (C, right) Context-dependent fear response plotted as freezing (% control) as a function of genotype and treatment conditions. Abbreviations: Saccharin (Sacc), Alcohol (Alc).
AD biomarker protein expression in specific brain regions of 3xTg-AD mice at 1-month post alcohol drinking. The title above each graph shows brain region and the AT(N) rubric for biomarker interpretation (see Table 2). (A-D, left) Mean ± SEM Aβ (42/40) ratio. (A-D, right) Total Tau protein expressed as mean ± SEM background corrected Median Fluorescence Intensity (MFI). Measures are plotted as a function of drinking history (S—saccharin; A—alcohol). * P < 0.05; ** P < 0.01, A vs S, t-test. WT control wells exhibited expression at background levels (data not shown).
pTau-Ser199/202 immunoreactivity (IR) in WT and 3xTg-AD mice 1-month post alcohol or saccharin drinking. (A) Coronal sections of dorsal hippocampus showing prominent IR in neuronal cell bodies and projections of CA1 only in 3xTg-AD mice with upregulation post alcohol (EtOH). (B) Basolateral amygdala (BLA) sections showing no alcohol-induced difference in pTau-Ser199/202 IR. Images acquired on Olympus BX51 microscope at 10× magnification.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AgogliaAE, & HermanMA (2018). The center of the emotional universe: Alcohol, stress, and CRF1 amygdala circuitry. Alcohol, 72, 61–73.3022058910.1016/j.alcohol.2018.03.009PMC6165695 | — | — | — |
| AgogliaAE, & HodgeCW (2017). Alcohol-induced alterations in the adolescent mouse prefrontal cortex proteome identify cannabinoid signaling as a mechanism of vulnerability to alcohol abuse. Alcoholism, Clinical and Experimental Research, 41, 202. | — | — | — |
| AgogliaAE, HolsteinSE, EastmanVR, & HodgeCW (2016). Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice. Pharmacology, Biochemistry, and Behavior, 143, 11–17.10.1016/j.pbb.2016.01.009PMC490582126800788 | — | — | — |
| AgogliaAE, HolsteinSE, ReidG, & HodgeCW (2015). CaMKIIalpha-GluA1 activity underlies vulnerability to adolescent binge alcohol drinking. Alcoholism, Clinical and Experimental Research, 39, 1680–1690.10.1111/acer.12819PMC455833026247621 | — | — | — |
| AgogliaAE, HolsteinSE, SmallAT, SpanosM, BurrusBM, & HodgeCW (2017). Comparison of the adolescent and adult mouse prefrontal cortex proteome. PLoS One, 12, e0178391.2857064410.1371/journal.pone.0178391PMC5453624 | — | — | — |
| AgogliaAE, SharkoAC, PsilosKE, HolsteinSE, ReidGT, & HodgeCW (2015). Alcohol alters the activation of ERK1/2, a functional regulator of binge alcohol drinking in adult C57BL/6J mice. Alcoholism, Clinical and Experimental Research, 39, 463–475.10.1111/acer.12645PMC434817325703719 | — | — | — |
| AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7, 270–279.10.1016/j.jalz.2011.03.008PMC331202721514249 | — | — | — |
| Alzheimer’s-Association. (2016). 2016 Alzheimer’s disease facts and figures. Alzheimer’s &Dementia: The Journal of the Alzheimer’s Association, 12, 459–509.10.1016/j.jalz.2016.03.00127570871 | — | — | — |
| Alzheimer’s-Association. (2019). 2019 Alzheimer’s disease facts and figures. Alzheimer’s &Dementia: The Journal of the Alzheimer’s Association, 15, 321–387. | — | — | — |
| AnW-L, CowburnRF, LiL, BraakH, AlafuzoffI, IqbalK, (2003). Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer’s disease. The American Journal of Pathology, 163, 591–607.1287597910.1016/S0002-9440(10)63687-5PMC1868198 | — | — | — |
| AvilaJ, León-EspinosaG, GarcíaE, García-EscuderoV, HernándezF, & DefelipeJ (2012). Tau phosphorylation by GSK3 in different conditions. International Journal of Alzheimer’s Disease, 2012, 578373.10.1155/2012/578373PMC336284622675648 | — | — | — |
| BallatoreC, LeeVM, & TrojanowskiJQ (2007). Tau-mediated neurodegeneration inAlzheimer’s disease and related disorders. Nature Reviews Neuroscience, 8, 663–672.1768451310.1038/nrn2194 | — | — | — |
| BeckerJB, & KoobGF (2016). Sex differences in animal models: Focus on addiction. Pharmacological Reviews, 68, 242–263.2677279410.1124/pr.115.011163PMC4813426 | — | — | — |
| BenilovaI, KarranE, & De StrooperB (2012). The toxic Abeta oligomer and Alzheimer’s disease: An emperor in need of clothes. Nature Neuroscience, 15, 349–357.2228617610.1038/nn.3028 | — | — | — |
| BesheerJ, & HodgeCW (2005). Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha1-containing receptors in the discriminative stimulus effects of ethanol. Neuropsychopharmacology, 30, 747–757.1554905410.1038/sj.npp.1300616PMC2892057 | — | — | — |
| BesheerJ, CoxAA, & HodgeCW (2003). Coregulation of ethanol discrimination by the nucleus accumbens and amygdala. Alcoholism, Clinical and Experimental Research, 27, 450–456.10.1097/01.ALC.0000057036.64169.C112658110 | — | — | — |
| BesheerJ, FisherKR, CannadyR, GrondinJJ, & HodgeCW (2012). Intra-amygdala inhibition of ERK(1/2) potentiates the discriminative stimulus effects of alcohol. Behavioural Brain Research, 228, 398–405.2220985310.1016/j.bbr.2011.12.023PMC3268949 | — | — | — |
| BesheerJ, LepoutreV, MoleB, & HodgeCW (2006). GABAA receptor regulation of voluntary ethanol drinking requires PKCepsilon. Synapse, 60, 411–419.1688107010.1002/syn.20314PMC2864065 | — | — | — |
| BillingsLM, OddoS, GreenKN, McGaughJL, & LaFerlaFM (2005). Intraneuronal Abeta causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron, 45, 675–688.1574884410.1016/j.neuron.2005.01.040 | — | — | — |
| BittnerN, JockwitzC, MuhleisenTW, HoffstaedterF, EickhoffSB, MoebusS, (2019). Combining lifestyle risks to disentangle brain structure and functional connectivity differences in older adults. Nature Communications, 10, 621.10.1038/s41467-019-08500-xPMC636556430728360 | — | — | — |
| BraakH, & BraakE (1991). Neuropathological stageing of Alzheimer-related changes.Acta Neuropathologica, 82, 239–259.175955810.1007/BF00308809 | — | — | — |
| BraakH, & BraakE (1998). Evolution of neuronal changes in the course of Alzheimer’s disease. Journal of Neural Transmission. Supplementum, 53, 127–140.970065110.1007/978-3-7091-6467-9_11 | — | — | — |
| BreslowRA, CastleIP, ChenCM, & GraubardBI (2017). Trends in alcohol consumption among older Americans: National Health Interview Surveys, 1997 to 2014. Alcoholism, Clinical and Experimental Research, 41, 976–986.10.1111/acer.13365PMC543949928340502 | — | — | — |
| BuckleyRF, VillemagneVL, MastersCL, EllisKA, RoweCC, JohnsonK, (2016). A conceptualization of the utility of subjective cognitive decline in clinical trials of preclinical Alzheimer’s disease. Journal of Molecular Neuroscience, 60, 354–361.2751452610.1007/s12031-016-0810-zPMC5241130 | — | — | — |
| CaccamoA, BelfioreR, & OddoS (2018). Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer’s disease. Neurobiology of Aging, 68, 59–67.2972942210.1016/j.neurobiolaging.2018.03.032PMC6777740 | — | — | — |
| CaiZ, ZhaoY, & ZhaoB (2012). Roles of glycogen synthase kinase 3 in Alzheimer’s disease. Current Alzheimer Research, 9, 864–879.2227262010.2174/156720512802455386 | — | — | — |
| CannadyR, FisherKR, GrahamC, CrayleJ, BesheerJ, & HodgeCW (2017). Potentiation of amygdala AMPA receptor activity selectively promotes escalated alcohol self-administration in a CaMKII-dependent manner. Addiction Biology, 22, 652–664.2674280810.1111/adb.12357PMC4935658 | — | — | — |
| CannadyR, GrondinJJ, FisherKR, HodgeCW, & BesheerJ (2011). Activation of group II metabotropic glutamate receptors inhibits the discriminative stimulus effects of alcohol via selective activity within the amygdala. Neuropsychopharmacology, 36, 2328–2338.2173465110.1038/npp.2011.121PMC3176569 | — | — | — |
| ChandranA, IyoAH, JerniganCS, LegutkoB, AustinMC, & KarolewiczB (2013). Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 40, 240–245.2288986310.1016/j.pnpbp.2012.08.001PMC3519947 | — | — | — |
| ChangRY, NouwensAS, DoddPR, & EtheridgeN (2013). The synaptic proteome in Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 9, 499–511.10.1016/j.jalz.2012.04.00923154051 | — | — | — |
| CharrierE, ReibelS, RogemondV, AgueraM, ThomassetN, & HonnoratJ (2003). Collapsin response mediator proteins (CRMPs): Involvement in nervous system development and adult neurodegenerative disorders. Molecular Neurobiology, 28, 51–64.1451498510.1385/MN:28:1:51 | — | — | — |
| ChauftyJ, SullivanSE, & HoA (2012). Intracellular amyloid precursor protein sorting and amyloid-beta secretion are regulated by Src-mediated phosphorylation of Mint2. The Journal of Neuroscience, 32, 9613–9625.2278704710.1523/JNEUROSCI.0602-12.2012PMC3404619 | — | — | — |
| ChengY, HuangCCY, MaT, WeiX, WangX, LuJ, (2017). Distinct synaptic strengthening of the striatal direct and indirect pathways drives alcohol consumption. Biological Psychiatry, 81, 918–929.2747016810.1016/j.biopsych.2016.05.016PMC5124556 | — | — | — |
| CherrierMM, MendezM, & PerrymanK (2001). Route learning performance in Alzheimer disease patients. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14, 159–168.11513099 | — | — | — |
| ChuJ, GiannopoulosPF, Ceballos-DiazC, GoldeTE, & PraticoD (2012). 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease. Annals of Neurology, 72, 442–454.2303491610.1002/ana.23642PMC3464917 | — | — | — |
| ChungJA, & CummingsJL (2000). Neurobehavioral and neuropsychiatric symptoms in Alzheimer’s disease: Characteristics and treatment. Neurologic Clinics, 18, 829–846.1107226310.1016/s0733-8619(05)70228-0 | — | — | — |
| ColeAR, NobleW, van AaltenL, PlattnerF, MeimaridouR, HoganD, (2007). Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer’s disease progression. Journal of Neurochemistry, 103, 1132–1144.1768348110.1111/j.1471-4159.2007.04829.x | — | — | — |
| CunninghamLA, NewvilleJ, LiL, TapiaP, AllanAM, & ValenzuelaCF (2017). Prenatal alcohol exposure leads to enhanced serine 9 phosphorylation of glycogen synthase kinase-3beta (GSK-3beta) in the hippocampal dentate gyrus of adult mouse. Alcoholism, Clinical and Experimental Research, 41, 1907–1916.10.1111/acer.13489PMC565990428865114 | — | — | — |
| de la MonteSM, GanjuN, TanakaS, BanerjeeK, KarlPJ, BrownNV, (1999). Differential effects of ethanol on insulin-signaling through the insulin receptor substrate-1. Alcoholism: Clinical and Experimental Research, 23, 770–777.10.1097/00000374-199905000-0000210371394 | — | — | — |
| DonovanLE, HigginbothamL, DammerEB, GearingM, ReesHD, XiaQ, (2012). Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer’s disease. Proteomics. Clinical Applications, 6, 201–211.2253245610.1002/prca.201100068PMC3338199 | — | — | — |
| EspanaJ, Gimenez-LlortL, ValeroJ, MinanoA, RabanoA, Rodriguez-AlvarezJ, (2010). Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer’s disease transgenic mice. Biological Psychiatry, 67, 513–521.1966475710.1016/j.biopsych.2009.06.015 | — | — | — |
| EwersM, MorganDG, GordonMN, & Woodruff-PakDS (2006). Associative and motor learning in 12-month-old transgenic APP+PS1 mice. Neurobiology of Aging, 27, 1118–1128.1599398510.1016/j.neurobiolaging.2005.05.019 | — | — | — |
| FaccidomoS, HolsteinSE, SantanamTS, SaundersBL, SwaimKS, ReidGT, (2019). Pharmacological inhibition of glycogen synthase kinase 3 increases operant alcohol self-administration in a manner associated with altered pGSK-3β, PICK1 and GluA2 protein expression in the reward pathway of male C57BL/6J mice. Behavioural Pharmacology. 10.1097/FBP.0000000000000501. (Epub ahead of print).PMC695429831503067 | — | — | — |
| FaccidomoS, ReidGT, AgogliaAE, AdemolaSA, & HodgeCW (2016). CaMKII inhibition in the prefrontal cortex specifically increases the positive reinforcing effects of sweetened alcohol in C57BL/6J mice. Behavioural Brain Research, 298, 286–290.2660853810.1016/j.bbr.2015.11.018PMC4688209 | — | — | — |
| FaccidomoS, SallingMC, GalunasC, & HodgeCW (2015). Operant ethanol self-administration increases extracellular-signal regulated protein kinase (ERK) phosphorylation in reward-related brain regions: Selective regulation of positive reinforcement in the prefrontal cortex of C57BL/6J mice. Psychopharmacology, 232, 3417–3430.2612332110.1007/s00213-015-3993-zPMC4537834 | — | — | — |
| FaccidomoS, SwaimKS, SaundersBL, SantanamTS, TaylorSM, KimM, (2018). Mining the nucleus accumbens proteome for novel targets of alcohol self-administration in male C57BL/6J mice. Psychopharmacology, 235, 1681–1696.2950227610.1007/s00213-018-4870-3PMC5949261 | — | — | — |
| FerrettiL, McCurrySM, LogsdonR, GibbonsL, & TeriL (2001). Anxiety and Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 14, 52–58.1128131710.1177/089198870101400111 | — | — | — |
| FilaliM, LalondeR, TheriaultP, JulienC, CalonF, & PlanelE (2012). Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer’s disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behavioural Brain Research, 234, 334–342.2279660110.1016/j.bbr.2012.07.004 | — | — | — |
| FranceschiC, GaragnaniP, MorsianiC, ConteM, SantoroA, GrignolioA, (2018). The continuum of aging and age-related diseases: Common mechanisms but different rates. Frontiers in Medicine, 5, 61.2966288110.3389/fmed.2018.00061PMC5890129 | — | — | — |
| FranklinKBJ, & PaxinosG (2001). The mouse brain in stereotaxic coordinates (2nd ed.).New York: Academic Press. | — | — | — |
| FuX, GuoZ, GaoC, ChuQ, LiJ, MaH, (2016). Long-term alcohol-induced activation of mammalian target of rapamycin is a key risk factor of epilepsy. Medical Science Monitor, 22, 3975–3980.2777917710.12659/MSM.897018PMC5091218 | — | — | — |
| FuY, ZhaoD, PanB, WangJ, CuiY, ShiF, (2015). Proteomic analysis of protein expression throughout disease progression in a mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease: JAD, 47, 915–926.2640177110.3233/JAD-150312 | — | — | — |
| GamesD, (1995). Alzheimer-type neuropathology in transgenic mice overexpressingV717F β-amyloid precursor protein. Nature, 373, 523–527.784546510.1038/373523a0 | — | — | — |
| Garvock-de MontbrunT, FertanE, StoverK, & BrownRE (2019). Motor deficits in 16-month-old male and female 3xTg-AD mice. Behavioural Brain Research, 356, 305–313.3020829510.1016/j.bbr.2018.09.006 | — | — | — |
| GeyerMA, & SwerdlowNR (2001). Measurement of startle response, prepulse inhibition, and habituation. Current Protocols in Neuroscience, Chapter 8 Unit 8.7.10.1002/0471142301.ns0807s0318428548 | — | — | — |
| GiannakopoulosP, HerrmannFR, BussiereT, BourasC, KovariE, PerlDP, (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology, 60, 1495–1500.1274323810.1212/01.wnl.0000063311.58879.01 | — | — | — |
| Gimenez-LlortL, BlazquezG, CaneteT, JohanssonB, OddoS, TobenaA, (2007). Modeling behavioral and neuronal symptoms of Alzheimer’s disease in mice: A role for intraneuronal amyloid. Neuroscience and Biobehavioral Reviews, 31, 125–147.1705557910.1016/j.neubiorev.2006.07.007 | — | — | — |
| GotoK, UekiA, IsoH, & MoritaY (2002). Reduced prepulse inhibition in rats with entorhinal cortex lesions. Behavioural Brain Research, 134, 201–207.1219180610.1016/s0166-4328(02)00039-6 | — | — | — |
| GriffinRJ, MoloneyA, KelliherM, JohnstonJA, RavidR, DockeryP, (2005). Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer’s disease pathology. Journal of Neurochemistry, 93, 105–117.1577391010.1111/j.1471-4159.2004.02949.x | — | — | — |
| GulinelloM, GertnerM, MendozaG, SchoenfeldBP, OddoS, LaFerlaF, (2009). Validation of a 2-day water maze protocol in mice. Behavioural Brain Research, 196, 220–227.1883199010.1016/j.bbr.2008.09.002PMC4303046 | — | — | — |
| HagnerPR, Mazan-MamczarzK, DaiB, CorlS, ZhaoXF, & GartenhausRB (2009). Alcohol consumption and decreased risk of non-Hodgkin lymphoma: Role of mTOR dysfunction. Blood, 113, 5526.1929342410.1182/blood-2008-11-191783 | — | — | — |
| HardyJ, & SelkoeDJ (2002). The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science, 297, 353–356.1213077310.1126/science.1072994 | — | — | — |
| HensleyK, GabbitaSP, VenkovaK, HristovA, JohnsonMF, EslamiP, (2013). A derivative of the brain metabolite lanthionine ketimine improves cognition and diminishes pathology in the 3 × Tg-AD mouse model of Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 72, 955–969.2404219810.1097/NEN.0b013e3182a74372 | — | — | — |
| HensleyK, VenkovaK, ChristovA, GunningW, & ParkJ (2011). Collapsin response mediator protein-2: An emerging pathologic feature and therapeutic target for neurodisease indications. Molecular Neurobiology, 43, 180–191.2127130410.1007/s12035-011-8166-4 | — | — | — |
| HernandezF (2013). GSK3 and tau: Two convergence points in Alzheimer’s disease. Journal of Alzheimer’s disease: JAD, 33(Suppl. 1), S141–S144.2271091410.3233/JAD-2012-129025 | — | — | — |
| HersiM, IrvineB, GuptaP, GomesJ, BirkettN, & KrewskiD (2017). Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence. Neurotoxicology, 61, 143–187.2836350810.1016/j.neuro.2017.03.006 | — | — | — |
| HodgeCW, ChappelleAM, & SamsonHH (1996). Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding. Alcoholism, Clinical and Experimental Research, 20, 1631–1638.10.1111/j.1530-0277.1996.tb01709.x8986215 | — | — | — |
| HodgeCW, MehmertKK, KelleySP, McMahonT, HaywoodA, OliveMF, (1999). Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nature Neuroscience, 2, 997–1002.1052633910.1038/14795 | — | — | — |
| HoenigK, HochreinA, QuednowBB, MaierW, & WagnerM (2005). Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biological Psychiatry, 57, 1153–1158.1586655510.1016/j.biopsych.2005.01.040 | — | — | — |
| HolcombLA, GordonMN, JantzenP, HsiaoK, DuffK, & MorganD (1999). Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits. Behavior Genetics, 29, 177–185.1054792410.1023/a:1021691918517 | — | — | — |
| HolsteinSE, SpanosM, & HodgeCW (2011). Adolescent C57BL/6J mice show elevated alcohol intake, but reduced taste aversion, as compared to adult mice: A potential behavioral mechanism for binge drinking. Alcoholism, Clinical and Experimental Research, 35, 1842–1851.10.1111/j.1530-0277.2011.01528.xPMC315830321575017 | — | — | — |
| HooperC, KillickR, & LovestoneS (2008). The GSK3 hypothesis of Alzheimer’s disease. Journal of Neurochemistry, 104, 1433–1439.1808838110.1111/j.1471-4159.2007.05194.xPMC3073119 | — | — | — |
| HsiaoK, ChapmanP, NilsenS, EckmanC, HarigayaY, YounkinS, (1996). Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science, 274, 99–103.881025610.1126/science.274.5284.99 | — | — | — |
| HuangD, YuM, YangS, LouD, ZhouW, ZhengL, (2018). Ethanol alters APP processing and aggravates Alzheimer-associated phenotypes. Molecular Neurobiology, 55, 5006–5018.2879913710.1007/s12035-017-0703-3 | — | — | — |
| HuangHJ, ChenSL, HuangHY, SunYC, LeeGC, Lee-ChenGJ, (2019). Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice. Psychopharmacology, 236, 763–773.3042618210.1007/s00213-018-5108-0PMC6469654 | — | — | — |
| HuberCM, YeeC, MayT, DhanalaA, & MitchellCS (2018). Cognitive decline in preclinical Alzheimer’s disease: Amyloid-beta versus tauopathy. Journal of Alzheimer’s Disease: JAD, 61, 265–281.2915427410.3233/JAD-170490PMC5734131 | — | — | — |
| IshiharaT, HongM, ZhangB, NakagawaY, LeeMK, TrojanowskiJQ, (1999). Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron, 24, 751–762.1059552410.1016/s0896-6273(00)81127-7 | — | — | — |
| JackCRJr., BennettDA, BlennowK, CarrilloMC, DunnB, HaeberleinSB, (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14, 535–562.10.1016/j.jalz.2018.02.018PMC595862529653606 | — | — | — |
| JacobsEH, WilliamsRJ, & FrancisPT (2006). Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11alpha protein up-regulation in Alzheimer’s disease. Neuroscience, 138, 511–522.1641313010.1016/j.neuroscience.2005.11.017 | — | — | — |
| JacobsJF, van der MolenRG, BossuytX, & DamoiseauxJ (2015). Antigen excess in modern immunoassays: To anticipate on the unexpected. Autoimmunity Reviews, 14, 160–167.2546146910.1016/j.autrev.2014.10.018 | — | — | — |
| JankowskyJL, & ZhengH (2017). Practical considerations for choosing a mouse model ofAlzheimer’s disease. Molecular Neurodegeneration, 12, 89.2927307810.1186/s13024-017-0231-7PMC5741956 | — | — | — |
| JankowskyJL, FadaleDJ, AndersonJ, XuGM, GonzalesV, JenkinsNA, (2003). Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: Evidence for augmentation of a 42-specific γ secretase. Human Molecular Genetics, 13, 159–170.1464520510.1093/hmg/ddh019 | — | — | — |
| JensenTMT, AlbertsenL, BartlingCRO, Haugaard-KedstromLM, & StromgaardK (2018). Probing the Mint2 protein-protein interaction network relevant to the pathophysiology of Alzheimer’s disease. Chembiochem. 10.1002/cbic.201800004. (Epub ahead of print).29578633 | — | — | — |
| JessenF, (2014). A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 10, 844–852.10.1016/j.jalz.2014.01.001PMC431732424798886 | — | — | — |
| Jin-JingP (2008). p70 S6 kinase and tau in Alzheimer’s disease. Journal of Alzheimer’s Disease:JAD, 14, 385–392.1868808810.3233/jad-2008-14405 | — | — | — |
| JungCH, RoS-H, CaoJ, OttoNM, & KimD-H (2010). mTOR regulation of autophagy. FEBS Letters, 584, 1287–1295.2008311410.1016/j.febslet.2010.01.017PMC2846630 | — | — | — |
| KhanUA, LiuL, ProvenzanoFA, BermanDE, ProfaciCP, SloanR, (2014). Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer’s disease. Nature Neuroscience, 17, 304–311.2436276010.1038/nn.3606PMC4044925 | — | — | — |
| KingMK, PardoM, ChengY, DowneyK, JopeRS, & BeurelE (2014). Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacology & Therapeutics, 141, 1–12.2391659310.1016/j.pharmthera.2013.07.010PMC3867580 | — | — | — |
| KohlS, HeekerenK, KlosterkotterJ, & KuhnJ (2013). Prepulse inhibition in psychiatric disorders—Apart from schizophrenia. Journal of Psychiatric Research, 47, 445–452.2328774210.1016/j.jpsychires.2012.11.018 | — | — | — |
| KoobGF, & VolkowND (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35, 217–238.1971063110.1038/npp.2009.110PMC2805560 | — | — | — |
| KramerA, GreenJ, PollardJJr., & TugendreichS (2014). Causal analysis approaches in ingenuity pathway analysis. Bioinformatics, 30, 523–530.2433680510.1093/bioinformatics/btt703PMC3928520 | — | — | — |
| Lafay-ChebassierC, PaccalinM, PageG, Barc-PainS, Perault-PochatMC, GilR, (2005). mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer’s disease. Journal of Neurochemistry, 94, 215–225.1595336410.1111/j.1471-4159.2005.03187.x | — | — | — |
| Lafay-ChebassierC, Perault-PochatMC, PageG, Rioux BilanA, DamjanacM, PainS, (2006). The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. Journal of Neuroscience Research, 84, 1323–1334.1695548410.1002/jnr.21039 | — | — | — |
| LalondeR, DumontM, StaufenbielM, & StrazielleC (2005). Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behavioural Brain Research, 157, 91–98.1561777510.1016/j.bbr.2004.06.020 | — | — | — |
| LewisB, GarciaCC, & NixonSJ (2018). Drinking patterns and adherence to “low-risk” guidelines among community-residing older adults. Drug and Alcohol Dependence, 187, 285–291.2969889510.1016/j.drugalcdep.2018.02.031PMC6324529 | — | — | — |
| LewisB, GarciaCC, BoissoneaultJ, PriceJL, & NixonSJ (2019). Working memory performance following acute alcohol: Replication and extension of dose by age interactions. Journal of Studies on Alcohol and Drugs, 80, 86–95.3080727910.15288/jsad.2019.80.86PMC6396508 | — | — | — |
| LiQ, & RenJ (2007). Chronic alcohol consumption alters mammalian target of rapamycin (mTOR), reduces ribosomal p70s6 kinase and p4E-BP1 levels in mouse cerebral cortex. Experimental Neurology, 204, 840–844.1729149910.1016/j.expneurol.2007.01.005PMC1895598 | — | — | — |
| LithfousS, DufourA, & DespresO (2013). Spatial navigation in normal aging and the prodromal stage of Alzheimer’s disease: Insights from imaging and behavioral studies. Ageing Research Reviews, 12, 201–213.2277171810.1016/j.arr.2012.04.007 | — | — | — |
| LiuF, LaguesseS, LegasteloisR, MorisotN, Ben HamidaS, & RonD (2017). mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors. Molecular Psychiatry, 22, 89–101.2695286510.1038/mp.2016.12PMC5097030 | — | — | — |
| Llorens-MartinM, JuradoJ, HernandezF, & AvilaJ (2014). GSK-3beta, a pivotal kinase in Alzheimer disease. Frontiers in Molecular Neuroscience, 7, 46.2490427210.3389/fnmol.2014.00046PMC4033045 | — | — | — |
| LynnBC, WangJ, MarkesberyWR, & LovellMA (2010). Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer’s disease. Journal of Alzheimer’s Disease: JAD, 19, 325–339.2006164810.3233/JAD-2010-1254PMC2905865 | — | — | — |
| LyPT, WuY, ZouH, WangR, ZhouW, KinoshitaA, (2013). Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. The Journal of Clinical Investigation, 123, 224–235.2320273010.1172/JCI64516PMC3533290 | — | — | — |
| MaQL, YangF, RosarioER, UbedaOJ, BeechW, GantDJ, (2009). Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin. The Journal of Neuroscience, 29, 9078–9089.1960564510.1523/JNEUROSCI.1071-09.2009PMC3849615 | — | — | — |
| Martins-De-SouzaD, Dias-NetoE, SchmittA, FalkaiP, GormannsP, MaccarroneG, (2010). Proteome analysis of schizophrenia brain tissue. The World Journal of Biological Psychiatry, 11, 110–120.2010911210.3109/15622970903490626 | — | — | — |
| MasurkarAV (2018). Towards a circuit-level understanding of hippocampal CA1 dysfunction in Alzheimer’s disease across anatomical axes. Journal of Alzheimer’s disease & Parkinsonism, 8, pii 412.PMC600519629928558 | — | — | — |
| McCoolBA, ChristianDT, DiazMR, & LackAK (2010). Glutamate plasticity in the drunken amygdala: The making of an anxious synapse. International Review of Neurobiology, 91, 205–233.2081324410.1016/S0074-7742(10)91007-6PMC3032604 | — | — | — |
| McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr., KawasCH, (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7, 263–269.10.1016/j.jalz.2011.03.005PMC331202421514250 | — | — | — |
| MegaMS, CummingsJL, FiorelloT, & GornbeinJ (1996). The spectrum of behavioral changes in Alzheimer’s disease. Neurology, 46, 130–135.855936110.1212/wnl.46.1.130 | — | — | — |
| MorrisRG, GarrudP, RawlinsJN, & O’KeefeJ (1982). Place navigation impaired in rats with hippocampal lesions. Nature, 297, 681–683.708815510.1038/297681a0 | — | — | — |
| MoussaMN, SimpsonSL, MayhughRE, GrataME, BurdetteJH, PorrinoLJ, (2014). Long-term moderate alcohol consumption does not exacerbate age-related cognitive decline in healthy, community-dwelling older adults. Frontiers in Aging Neuroscience, 6, 341.2560183510.3389/fnagi.2014.00341PMC4283638 | — | — | — |
| MuckeL, MasliahE, YuG-Q, MalloryM, RockensteinEM, TatsunoG, (2000). High-level neuronal expression of Aβ1–42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. The Journal of Neuroscience, 20, 4050–4058.1081814010.1523/JNEUROSCI.20-11-04050.2000PMC6772621 | — | — | — |
| MukamalKJ, LongstrethWTJr., MittlemanMA, CrumRM, & SiscovickDS (2001). Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: The cardiovascular health study. Stroke, 32, 1939–1946.1154687810.1161/hs0901.095723 | — | — | — |
| NeastaJ, BarakS, HamidaSB, & RonD (2014). mTOR complex 1: A key player in neuroadaptations induced by drugs of abuse. Journal of Neurochemistry, 130, 172–184.2466634610.1111/jnc.12725PMC4107045 | — | — | — |
| NeastaJ, Ben HamidaS, YowellQ, CarnicellaS, & RonD (2010). Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proceedings of the National Academy of Sciences of the United States of America, 107, 20093–20098.2104165410.1073/pnas.1005554107PMC2993345 | — | — | — |
| NeastaJ, Ben HamidaS, YowellQV, CarnicellaS, & RonD (2011). AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biological Psychiatry, 70, 575–582.2154935310.1016/j.biopsych.2011.03.019PMC3228847 | — | — | — |
| NeddensJ, TemmelM, FlunkertS, KerschbaumerB, HoellerC, LoefflerT, (2018). Phosphorylation of different tau sites during progression of Alzheimer’s disease. Acta Neuropathologica Communications, 6, 52.2995854410.1186/s40478-018-0557-6PMC6027763 | — | — | — |
| NIAAA. (2017). NIAAA strategic plan 2017–2021. National Institute on Alcohol Abuse and Alcoholism. https://www.niaaa.nih.gov/strategic-plan. | — | — | — |
| NorambuenaA, WallrabeH, McMahonL, SilvaA, SwansonE, KhanSS, (2017). mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 13, 152–167.10.1016/j.jalz.2016.08.015PMC531824827693185 | — | — | — |
| OakleyH, ColeSL, LoganS, MausE, ShaoP, CraftJ, (2006). Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. The Journal of Neuroscience, 26, 10129–10140.1702116910.1523/JNEUROSCI.1202-06.2006PMC6674618 | — | — | — |
| OddoS (2012). The role of mTOR signaling in Alzheimer disease. Frontiers in Bioscience (Scholar Edition), 4, 941–952.2220210110.2741/s310PMC4111148 | — | — | — |
| OddoS, CaccamoA, KitazawaM, TsengBP, & LaFerlaFM (2003). Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease. Neurobiology of Aging, 24, 1063–1070.1464337710.1016/j.neurobiolaging.2003.08.012 | — | — | — |
| OddoS, CaccamoA, ShepherdJD, MurphyMP, GoldeTE, KayedR, (2003). Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron, 39, 409–421.1289541710.1016/s0896-6273(03)00434-3 | — | — | — |
| OddoS, CaccamoA, TranL, LambertMP, GlabeCG, KleinWL, (2006). Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. The Journal of Biological Chemistry, 281, 1599–1604.1628232110.1074/jbc.M507892200 | — | — | — |
| OgataH, OgatoF, MendelsonJH, & MelloNK (1972). A comparison of techniques to induce alcohol dependence and tolerance in the mouse. The Journal of Pharmacology and Experimental Therapeutics, 180, 216–230.5062298 | — | — | — |
| OhnoM, ColeSL, YasvoinaM, ZhaoJ, CitronM, BerryR, (2007). BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiology of Disease, 26, 134–145.1725890610.1016/j.nbd.2006.12.008PMC1876698 | — | — | — |
| OliveMF, & HodgeCW (2000). Co-localization of PKCepsilon with various GABA (A) receptor subunits in the mouse limbic system. Neuroreport, 11, 683–687.1075750010.1097/00001756-200003200-00006 | — | — | — |
| PabstS, MargittaiM, VainiusD, LangenR, JahnR, & FasshauerD (2002). Rapid and selective binding to the synaptic SNARE complex suggests a modulatory role of complexins in neuroexocytosis. The Journal of Biological Chemistry, 277, 7838–7848.1175190710.1074/jbc.M109507200 | — | — | — |
| PaiMC, & JacobsWJ (2004). Topographical disorientation in community-residing patients with Alzheimer’s disease. International Journal of Geriatric Psychiatry, 19, 250–255.1502704010.1002/gps.1081 | — | — | — |
| PalmerAM (2002). Pharmacotherapy for Alzheimer’s disease: Progress and prospects. Trends in Pharmacological Sciences, 23, 426–433.1223715510.1016/s0165-6147(02)02056-4 | — | — | — |
| PalmerK, LupoF, PerriR, SalamoneG, FaddaL, CaltagironeC, (2011). Predicting disease progression in Alzheimer’s disease: The role of neuropsychiatric syndromes on functional and cognitive decline. Journal of Alzheimer’s Disease: JAD, 24, 35–45.2115701910.3233/JAD-2010-101836 | — | — | — |
| PandeySC, ZhangH, UgaleR, PrakashA, XuT, & MisraK (2008). Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. The Journal of Neuroscience, 28, 2589.1832210210.1523/JNEUROSCI.4752-07.2008PMC6671198 | — | — | — |
| PeiJ-J, & HugonJ (2008). mTOR-dependent signalling in Alzheimer’s disease. Journal ofCellular and Molecular Medicine, 12, 2525–2532.10.1111/j.1582-4934.2008.00509.xPMC382887119210753 | — | — | — |
| PhillipsRG, & LeDouxJE (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral Neuroscience, 106, 274–285.159095310.1037//0735-7044.106.2.274 | — | — | — |
| Piazza-GardnerAK, GaffudTJ, & BarryAE (2013). The impact of alcohol on Alzheimer’s disease: A systematic review. Aging & Mental Health, 17, 133–146.2317122910.1080/13607863.2012.742488 | — | — | — |
| PietropaoloS, FeldonJ, & YeeBK (2014). Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer’s disease. Cognitive, Affective, & Behavioral Neuroscience, 14, 996–1008.10.3758/s13415-014-0253-324492993 | — | — | — |
| PietrzakRH, LimYY, NeumeisterA, AmesD, EllisKA, HarringtonK, (2015). Amyloid-beta, anxiety, and cognitive decline in preclinical Alzheimer disease: A multicenter, prospective cohort study. JAMA Psychiatry, 72, 284–291.2562978710.1001/jamapsychiatry.2014.2476 | — | — | — |
| RaddeR, BolmontT, KaeserSA, CoomaraswamyJ, LindauD, StoltzeL, (2006). Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Reports, 7, 940–946.1690612810.1038/sj.embor.7400784PMC1559665 | — | — | — |
| RaskinJ, CummingsJ, HardyJ, SchuhK, & DeanRA (2015). Neurobiology of Alzheimer’s disease: Integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Current Alzheimer Research, 12, 712–722.2641221810.2174/1567205012666150701103107PMC5384474 | — | — | — |
| RiveraI, CaponeR, CauviDM, ArispeN, & De MaioA (2018). Modulation of Alzheimer’s amyloid beta peptide oligomerization and toxicity by extracellular Hsp70. Cell Stress & Chaperones, 23, 269–279.2895626810.1007/s12192-017-0839-0PMC5823807 | — | — | — |
| RobinsonRA, AminB, & GuestPC (2017). Multiplexing biomarker methods, proteomics and considerations for Alzheimer’s disease. Advances in Experimental Medicine and Biology, 974, 21–48.2835322310.1007/978-3-319-52479-5_2 | — | — | — |
| RockensteinE, TorranceM, AdameA, ManteM, Bar-onP, RoseJB, (2007). Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation. The Journal of Neuroscience, 27, 1981–1991.1731429410.1523/JNEUROSCI.4321-06.2007PMC6673566 | — | — | — |
| RomanoA, PaceL, TempestaB, LavecchiaAM, MachedaT, BedseG, (2014). Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer’s disease. The International Journal of Neuropsychopharmacology, 18, pyu020.10.1093/ijnp/pyu020PMC436022825609597 | — | — | — |
| RuitenbergA, van SwietenJC, WittemanJC, MehtaKM, van DuijnCM, HofmanA, (2002). Alcohol consumption and risk of dementia: The Rotterdam study. The Lancet, 359, 281–286.10.1016/S0140-6736(02)07493-711830193 | — | — | — |
| SacksJJ, GonzalesKR, BoucheryEE, TomediLE, & BrewerRD (2015). 2010 national and state costs of excessive alcohol consumption. American Journal of Preventive Medicine, 49, e73–e79.2647780710.1016/j.amepre.2015.05.031 | — | — | — |
| SallingMC, FaccidomoSP, LiC, PsilosK, GalunasC, SpanosM, (2016). Moderate alcohol drinking and the amygdala proteome: Identification and validation of calcium/calmodulin dependent kinase II and AMPA receptor activity as novel molecular mechanisms of the positive reinforcing effects of alcohol. Biological Psychiatry, 79, 430–442.2557985110.1016/j.biopsych.2014.10.020PMC4417085 | — | — | — |
| SallingMC, HodgeCJ, PsilosKE, EastmanVR, FaccidomoSP, & HodgeCW (2017). Cue-induced reinstatement of alcohol-seeking behavior is associated with increased CaMKII T286 phosphorylation in the reward pathway of mice. Pharmacology, Biochemistry, and Behavior, 163, 20–29.10.1016/j.pbb.2017.10.011PMC577962229100991 | — | — | — |
| SauraCA, ChenG, MalkaniS, ChoiSY, TakahashiRH, ZhangD, (2005). Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. The Journal of Neuroscience, 25, 6755–6764.1603388510.1523/JNEUROSCI.1247-05.2005PMC6725351 | — | — | — |
| SchroederJP, OliveF, KoenigH, & HodgeCW (2003). Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcoholism, Clinical and Experimental Research, 27, 1884–1891.10.1097/01.ALC.0000098875.95923.6914691375 | — | — | — |
| SchroederJP, SpanosM, StevensonJR, BesheerJ, SallingM, & HodgeCW (2008). Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: Blockade by the mGluR5 antagonist MPEP. Neuropharmacology, 55, 546–554.1861998410.1016/j.neuropharm.2008.06.057PMC2613007 | — | — | — |
| SerenoL, ComaM, RodriguezM, Sanchez-FerrerP, SanchezMB, GichI, (2009). A novel GSK-3beta inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo. Neurobiology of Disease, 35, 359–367.1952351610.1016/j.nbd.2009.05.025 | — | — | — |
| SimanR, CoccaR, & DongY (2015). The mTOR inhibitor rapamycin mitigates perforant pathway neurodegeneration and synapse loss in a mouse model of early-stage Alzheimer-type tauopathy. PLoS One, 10, e0142340.2654026910.1371/journal.pone.0142340PMC4634963 | — | — | — |
| SoutarMP, ThornhillP, ColeAR, & SutherlandC (2009). Increased CRMP2 phosphorylation is observed in Alzheimer’s disease; does this tell us anything about disease development? Current Alzheimer Research, 6, 269–278.1951930810.2174/156720509788486572 | — | — | — |
| SpanosM, BesheerJ, & HodgeCW (2012). Increased sensitivity to alcohol induced changes in ERK Map kinase phosphorylation and memory disruption in adolescent as compared to adult C57BL/6J mice. Behavioural Brain Research, 230, 158–166.2234889310.1016/j.bbr.2012.02.010PMC3310330 | — | — | — |
| SperlingRA, (2011). Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7, 280–292.10.1016/j.jalz.2011.03.003PMC322094621514248 | — | — | — |
| SquegliaLM, BoissoneaultJ, Van SkikeCE, NixonSJ, & MatthewsDB (2014). Age-related effects of alcohol from adolescent, adult, and aged populations using human and animal models. Alcoholism, Clinical and Experimental Research, 38, 2509–2516.10.1111/acer.12531PMC421193425156779 | — | — | — |
| StevensonJR, SchroederJP, NixonK, BesheerJ, CrewsFT, & HodgeCW (2009). Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology, 34, 1209–1222.1856305910.1038/npp.2008.90PMC2844649 | — | — | — |
| StoverKR, CampbellMA, Van WinssenCM, & BrownRE (2015a). Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer’s disease. Behavioural Brain Research, 289, 29–38.2589636210.1016/j.bbr.2015.04.012 | — | — | — |
| StoverKR, CampbellMA, Van WinssenCM, & BrownRE (2015b). Analysis of motor function in 6-month-old male and female 3xTg-AD mice. Behavioural Brain Research, 281, 16–23.2548617710.1016/j.bbr.2014.11.046 | — | — | — |
| Sturchler-PierratC, AbramowskiD, DukeM, WiederholdK-H, MistlC, RothacherS, (1997). Two amyloid precursor protein transgenic mouse models with Alzheimerdisease-likepathology. Proceedings of the National Academy of Sciences of the United States of America, 94, 13287–13292.937183810.1073/pnas.94.24.13287PMC24301 | — | — | — |
| SudhofTC (2013). Neurotransmitter release: The last millisecond in the life of a synaptic vesicle. Neuron, 80, 675–690.2418301910.1016/j.neuron.2013.10.022PMC3866025 | — | — | — |
| SuKY, ChienWL, FuWM, YuIS, HuangHP, HuangPH, (2007). Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. The Journal of Neuroscience, 27, 2513–2524.1734438910.1523/JNEUROSCI.4497-06.2007PMC6672508 | — | — | — |
| SwerdlowNR, GeyerMA, & BraffDL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology, 156, 194–215.1154922310.1007/s002130100799 | — | — | — |
| TakanoM, YamashitaT, NaganoK, OtaniM, MaekuraK, KamadaH, (2013). Proteomic analysis of the hippocampus in Alzheimer’s disease model mice by using two-dimensional fluorescence difference in gel electrophoresis. Neuroscience Letters, 534, 85–89.2327663910.1016/j.neulet.2012.11.010 | — | — | — |
| TangJ, MaximovA, ShinOH, DaiH, RizoJ, & SudhofTC (2006). A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell, 126, 1175–1187.1699014010.1016/j.cell.2006.08.030 | — | — | — |
| TaylorCA, GreenlundSF, McGuireLC, LuH, & CroftJB (2017). Deaths from Alzheimer’s disease—United States, 1999–2014. MMWR. Morbidity and Mortality Weekly Report, 66, 521–526.2854212010.15585/mmwr.mm6620a1PMC5657871 | — | — | — |
| TenreiroS, EckermannK, & OuteiroTF (2014). Protein phosphorylation in neurodegeneration: Friend or foe? Frontiers in Molecular Neuroscience, 7, 42.2486042410.3389/fnmol.2014.00042PMC4026737 | — | — | — |
| ThomasVS, & RockwoodKJ (2001). Alcohol abuse, cognitive impairment, and mortality among older people. Journal of the American Geriatrics Society, 49, 415–420.1134778510.1046/j.1532-5415.2001.49085.x | — | — | — |
| TopiwalaA, AllanCL, ValkanovaV, ZsoldosE, FilippiniN, SextonC, (2017). Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: Longitudinal cohort study. BMJ, 357, j2353.2858806310.1136/bmj.j2353PMC5460586 | — | — | — |
| TramutolaA, TriplettJC, Di DomenicoF, NiedowiczDM, MurphyMP, CocciaR, (2015). Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): Analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. Journal of Neurochemistry, 133, 739–749.2564558110.1111/jnc.13037 | — | — | — |
| TruelsenT, ThudiumD, GronbaekM, & Copenhagen City Heart Study. (2002). Amount and type of alcohol and risk of dementia: The Copenhagen City Heart Study. Neurology, 59, 1313–1319.1242787610.1212/01.wnl.0000031421.50369.e7 | — | — | — |
| UekiA, GotoK, SatoN, IsoH, & MoritaY (2006). Prepulse inhibition of acoustic startle response in mild cognitive impairment and mild dementia of Alzheimer type. Psychiatry and Clinical Neurosciences, 60, 55–62.1647235910.1111/j.1440-1819.2006.01460.x | — | — | — |
| UenoS, HarrisRA, MessingRO, Sanchez-PerezAM, HodgeCW, McMahonT, (2001). Alcohol actions on GABA(A) receptors: From protein structure to mouse behavior. Alcoholism, Clinical and Experimental Research, 25, 76S–81S.10.1097/00000374-200105051-0001411391054 | — | — | — |
| van der VaartA, MengX, BowersMS, BatmanAM, AlievF, FarrisSP, (2018). Glycogen synthase kinase 3 beta regulates ethanol consumption and is a risk factor for alcohol dependence. Neuropsychopharmacology, 43, 2521–2531.3018851710.1038/s41386-018-0202-xPMC6224501 | — | — | — |
| VelazquezR, TranA, IshimweE, DennerL, DaveN, OddoS, (2017). Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer’s disease. Neurobiology of Aging, 58, 1–13.2868889910.1016/j.neurobiolaging.2017.06.003PMC5819888 | — | — | — |
| VillemagneVL, BurnhamS, BourgeatP, BrownB, EllisKA, SalvadoO, (2013). Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study. The Lancet. Neurology, 12, 357–367.2347798910.1016/S1474-4422(13)70044-9 | — | — | — |
| WangC, YuJ-T, MiaoD, WuZ-C, TanM-S, & TanL (2014). Targeting the mTOR signaling network for Alzheimer’s disease therapy. Molecular Neurobiology, 49, 120–135.2385304210.1007/s12035-013-8505-8 | — | — | — |
| WebsterSJ, BachstetterAD, NelsonPT, SchmittFA, & Van EldikLJ (2014). Using mice to model Alzheimer’s dementia: An overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Frontiers in Genetics, 5, 88.2479575010.3389/fgene.2014.00088PMC4005958 | — | — | — |
| WeyererS, SchaufeleM, WieseB, MaierW, TebarthF, van den BusscheH, (2011). Current alcohol consumption and its relationship to incident dementia: Results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age and Ageing, 40, 456–463.2136776410.1093/ageing/afr007 | — | — | — |
| WhitwellJL (2010). Progression of atrophy in Alzheimer’s disease and related disorders.Neurotoxicity Research, 18, 339–346.2035239610.1007/s12640-010-9175-1 | — | — | — |
| WHO. (2018). Global status report on alcohol and health. Geneva: WHO Press. | — | — | — |
| WolenAR, PhillipsCA, LangstonMA, PutmanAH, VorsterPJ, BruceNA, (2012). Genetic dissection of acute ethanol responsive gene networks in prefrontal cortex: Functional and mechanistic implications. PLoS One, 7, e33575.2251192410.1371/journal.pone.0033575PMC3325236 | — | — | — |
| WoodgettJR (1990). Molecular cloning and expression of glycogen synthase kinase-3/factor A. The EMBO Journal, 9, 2431–2438.216447010.1002/j.1460-2075.1990.tb07419.xPMC552268 | — | — | — |
| XiaoNA, ZhangJ, ZhouM, WeiZ, WuXL, DaiXM, (2015). Reduction of glucose metabolism in olfactory bulb is an earlier Alzheimer’s disease-related biomarker in 5XFAD mice. Chinese Medical Journal, 128, 2220–2227.2626561710.4103/0366-6999.162507PMC4717990 | — | — | — |
| XuYY, BhavaniK, WandsJR, & de la MonteSM (1995). Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression. Biochemical Journal, 310(Pt. 1), 125–132.764643410.1042/bj3100125PMC1135863 | — | — | — |
| YoshidaH, WatanabeA, & IharaY (1998). Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer’s disease. The Journal of Biological Chemistry, 273, 9761–9768.954531310.1074/jbc.273.16.9761 | — | — | — |
| YoshiyamaY, HiguchiM, ZhangB, HuangS-M, IwataN, Saido TakaomiC, (2007). Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron, 53, 337–351.1727073210.1016/j.neuron.2007.01.010 | — | — | — |
| YuJS, & CuiW (2016). Proliferation, survival and metabolism: The role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development, 143, 3050–3060.2757817610.1242/dev.137075 | — | — | — |
| ZilkensRR, BruceDG, DukeJ, SpilsburyK, & SemmensJB (2014). Severe psychiatric disorders in mid-life and risk of dementia in late-life (age 65–84 years): A population based case-control study. Current Alzheimer Research, 11, 681–693.2511554110.2174/1567205011666140812115004PMC4153082 | — | — | — |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases. | 2021 | 34417470 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alcohol-Induced Dysregulation of Hydrogen Sulfide Signaling in Alzheimer's Disease-<i>Narrative Mechanistic Synthesis Review</i>. | Munteanu C et al. | — | 2026 | → |
| Increased alcohol drinking and seizure susceptibility in female humanized ApoE4 knockin rats. | Choi CY et al. | — | 2026 | → |
| Adolescent Alcohol and the Spectrum of Cognitive Dysfunction in Aging. | Deak T et al. | — | 2025 | → |
| Alcohol consumption during early adulthood increases the vulnerability of locus coeruleus neurons and amyloid beta pathology in female APP/PS1 mice. | Engel S et al. | — | 2025 | → |
| Cerebral amyloid angiopathy: a narrative review. | Noto NM et al. | — | 2025 | → |
| Chronic alcohol exposure during young adulthood attenuates microglial reactivity and downstream immune response pathways in a mouse model of tauopathy later in life. | Wolf T et al. | — | 2025 | → |
| Chronic Alcohol Use and Accelerated Brain Aging: Shared Mechanisms with Alzheimer's Disease Pathophysiology. | Singh N et al. | — | 2025 | → |
| Chronic ethanol administration exacerbates memory loss by altering N6-methyladenosine-mediated epigenetic signaling. | Liao Y et al. | — | 2025 | → |
| Cognitive and cerebral phenotypes of neurocognitive disorders due to alcohol or Alzheimer's disease. | Soussi C et al. | — | 2025 | → |
| Effect of chronic alcohol feeding using the Lieber-DeCarli diet on Alzheimer's disease pathology in Tg2576 mice. | Chandrashekar DV et al. | — | 2025 | → |
| Ethanol Increases Diffuse Amyloid Plaque Load and Impairs Memory in the 5xFAD Mouse Model of Alzheimer's Disease. | Le L et al. | — | 2025 | → |
| Examination of age- and sex-related changes in protein expression within the hippocampus and prefrontal cortex during withdrawal from a subchronic history of binge-drinking in C57BL/6J mice. | Jimenez Chavez CL et al. | — | 2025 | → |
| Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence. | Anton PE et al. | — | 2025 | → |
| Inhibition of PDE4B ameliorates cognitive defects in the model of alcoholic dementia in 3xTg-AD mice via PDE4B/cAMP/PKA signaling. | Sun R et al. | — | 2025 | → |
| Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non-human primate models. | Jin Z et al. | — | 2025 | → |
| Interconnected Pathways of Alzheimer's Disease and Osteoporosis: A Review of Genetic, Hormonal, and Environmental Influences. | Li YX et al. | — | 2025 | → |
| Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline. | Barnett AM et al. | — | 2025 | → |
| Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer's disease in cerebrospinal fluid. | Hou X et al. | — | 2025 | → |
| Pre-Reproductive Excessive Alcohol and Maternal Immune Activation Differentially Affect Offspring Behavior, Neurobiology, and Brain Volume in a Sex-Dependent Manner. | Ott A et al. | — | 2025 | → |
| Relationships among osteoporosis, redox homeostasis, and alcohol addiction: Importance of the brain-bone axis. | Martiniakova M et al. | — | 2025 | → |
| Sex-specific effects of chronic alcohol consumption across the lifespan in the transgenic Alzheimer's Disease (TgF344-AD) rat model. | Marsland P et al. | — | 2025 | → |
| Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker. | Rebolledo-Pérez L et al. | — | 2025 | → |
| The Role of Genetic, Environmental, and Dietary Factors in Alzheimer's Disease: A Narrative Review. | Mertaş B et al. | — | 2025 | → |
| Transmembrane AMPA receptor regulatory protein TARP ɣ-8 is a target of ethanol that regulates self-administration and relapse in mice. | Faccidomo S et al. | — | 2025 | → |
| Alcohol and stress exposure across the lifespan are key risk factors for Alzheimer's Disease and cognitive decline. | Seemiller LR et al. | — | 2024 | → |
| Alcohol Use Disorder and Dementia: A Review. | Zahr NM | — | 2024 | → |
| Binge ethanol exposure in advanced age elevates neuroinflammation and early indicators of neurodegeneration and cognitive impairment in female mice. | Anton PE et al. | — | 2024 | → |
| Biochemical changes precede affective and cognitive anomalies in aging adult C57BL/6J mice with a prior history of adolescent alcohol binge-drinking. | Chavez CLJ et al. | — | 2024 | → |
| Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies. | Pomella S et al. | — | 2024 | → |
| Distinct sex differences in ethanol consumption and operant self-administration in C57BL/6J mice with uniform regulation by glutamate AMPAR activity. | Faccidomo S et al. | — | 2024 | → |
| Early-Stage Moderate Alcohol Feeding Dysregulates Insulin-Related Metabolic Hormone Expression in the Brain: Potential Links to Neurodegeneration Including Alzheimer's Disease. | Yang Y et al. | — | 2024 | → |
| Ethanol Exacerbates the Alzheimer's Disease Pathology in the 5xFAD Mouse Model. | Mohammed HE et al. | — | 2024 | → |
| Exercise leads to sex-specific recovery of behavior and pathological AD markers following adolescent ethanol exposure in the TgF344-AD model. | Reitz NL et al. | — | 2024 | → |
| Experimental laboratory models as tools for understanding modifiable dementia risk. | Sinclair D et al. | — | 2024 | → |
| Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding. | Chandrashekar DV et al. | — | 2024 | → |
| Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP/PS1 mice. | Kang S et al. | — | 2024 | → |
| Microcephaly Gene <i>Mcph1</i> Deficiency Induces p19ARF-Dependent Cell Cycle Arrest and Senescence. | Jiang YN et al. | — | 2024 | → |
| Acute and Chronic Ethanol Effects during Adolescence on Neuroimmune Responses: Consequences and Potential Pharmacologic Interventions. | Nwachukwu KN et al. | — | 2023 | → |
| A History of Repeated Alcohol Intoxication Promotes Cognitive Impairment and Gene Expression Signatures of Disease Progression in the 3xTg Mouse Model of Alzheimer's Disease. | Sanna PP et al. | — | 2023 | → |
| Alcohol as a Modifiable Risk Factor for Alzheimer's Disease-Evidence from Experimental Studies. | Chandrashekar DV et al. | — | 2023 | → |
| Alcohol-drinking during later life by C57BL/6J mice induces sex- and age-dependent changes in hippocampal and prefrontal cortex expression of glutamate receptors and neuropathology markers. | Szumlinski KK et al. | — | 2023 | → |
| A perspective on autophagy and transcription factor EB in Alcohol-Associated Alzheimer's disease. | Zhang C et al. | — | 2023 | → |
| A subchronic history of binge-drinking elicits mild, age- and sex-selective, affective, and cognitive anomalies in C57BL/6J mice. | Jimenez Chavez CL et al. | — | 2023 | → |
| Chemical Genetic Identification of PKC Epsilon Substrates in Mouse Brain. | Dugan MP et al. | — | 2023 | → |
| Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease. | Wang Q et al. | — | 2023 | → |
| Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders. | Gupta R et al. | — | 2023 | → |
| Dysregulation of tryptophan metabolism and distortion of cell signaling after oral exposure to ethanol and Kynurenic acid. | Yang C et al. | — | 2023 | → |
| Ethanol exposure alters Alzheimer's-related pathology, behavior, and metabolism in APP/PS1 mice. | Day SM et al. | — | 2023 | → |
| Fetal alcohol exposure impairs learning and memory functions and elevates levels of various biochemical markers of Alzheimer's disease in the brain of 12-month-old rats. | Chaudhary S et al. | — | 2023 | → |
| Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer's disease. | Seike T et al. | — | 2023 | → |
| Inflammation and aging: signaling pathways and intervention therapies. | Li X et al. | — | 2023 | → |
| Neuroprotective Effects of IVIG against Alzheimer' s Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice. | Fei Z et al. | — | 2023 | → |
| Precocious emergence of cognitive and synaptic dysfunction in 3xTg-AD mice exposed prenatally to ethanol. | Tousley AR et al. | — | 2023 | → |
| Prenatal alcohol exposure causes persistent microglial activation and age- and sex- specific effects on cognition and metabolic outcomes in an Alzheimer's Disease mouse model. | Walter KR et al. | — | 2023 | → |
| Schedule-induced alcohol intake during adolescence sex dependently impairs hippocampal synaptic plasticity and spatial memory. | Sanz-Martos AB et al. | — | 2023 | → |
| Sex-specific effects of ethanol consumption in older Fischer 344 rats on microglial dynamics and Aβ<sub>(1-42)</sub> accumulation. | Marsland P et al. | — | 2023 | → |
| Substance abuse and neurodegenerative diseases: focus on ferroptosis. | Guo C et al. | — | 2023 | → |
| Tauopathy and alcohol consumption interact to alter locus coeruleus excitatory transmission and excitability in male and female mice. | Downs AM et al. | — | 2023 | → |
| The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration. | Masi M et al. | — | 2023 | → |
| Adolescent Binge Alcohol Enhances Early Alzheimer's Disease Pathology in Adulthood Through Proinflammatory Neuroimmune Activation. | Barnett A et al. | — | 2022 | → |
| Alcohol-Drinking Under Limited-Access Procedures During Mature Adulthood Accelerates the Onset of Cognitive Impairment in Mice. | Jimenez Chavez CL et al. | — | 2022 | → |
| Chromatin architecture in addiction circuitry identifies risk genes and potential biological mechanisms underlying cigarette smoking and alcohol use traits. | Sey NYA et al. | — | 2022 | → |
| Chronic Ethanol Causes Persistent Increases in Alzheimer's Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment. | Tucker AE et al. | — | 2022 | → |
| Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorder. | Tye SJ et al. | — | 2022 | → |
| Ethanol sustains phosphorylated tau protein in the cultured neonatal rat hippocampus: Implications for fetal alcohol spectrum disorders. | Bailey CS et al. | — | 2022 | → |
| Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice. | Li Q et al. | — | 2022 | → |
| <i>DPYSL2</i>/<i>CRMP2</i>isoform B knockout in human iPSC-derived glutamatergic neurons confirms its role in mTOR signaling and neurodevelopmental disorders | Feuer KL et al. | — | 2022 | — |
| Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer's disease. | Frausto DM et al. | — | 2022 | → |
| Innate immune activation: Parallels in alcohol use disorder and Alzheimer's disease. | Ramos A et al. | — | 2022 | → |
| Preventive Measures against the Development of Dementia in Old Age. | Ayenigbara IO | — | 2022 | → |
| The Effect of Chronic Alcohol on Cognitive Decline: Do Variations in Methodology Impact Study Outcome? An Overview of Research From the Past 5 Years. | Charlton AJ et al. | — | 2022 | → |
| Addiction-Associated Genetic Variants Implicate Brain Cell Type- and Region-Specific Cis-Regulatory Elements in Addiction Neurobiology. | Srinivasan C et al. | — | 2021 | → |
| Age and gender differences for the behavioral phenotypes of 3xTg alzheimer's disease mice. | Pairojana T et al. | — | 2021 | → |
| Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. | Wang ZT et al. | — | 2021 | → |
| Dietary Regulation of Gut-Brain Axis in Alzheimer's Disease: Importance of Microbiota Metabolites. | Frausto DM et al. | — | 2021 | → |
| IL-6 and IL-1β upregulation and tau protein phosphorylation in response to chronic alcohol exposure in the mouse hippocampus. | Jiang C et al. | — | 2021 | → |
| Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases. | Kapoor M et al. | — | 2021 | → |
| Alcohol Use Disorder, Neurodegeneration, Alzheimer's and Parkinson's Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity. | Kamal H et al. | — | 2020 | → |
| Potential Role of Extracellular CIRP in Alcohol-Induced Alzheimer's Disease. | Sharma A et al. | — | 2020 | → |
| Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. | Peng B et al. | — | 2020 | → |
| A comparison of hippocampal microglial responses in aged and young rodents following dependent and non-dependent binge drinking. | Grifasi IR et al. | — | 2019 | → |
| Preface: Setting the stage for understanding alcohol effects in late aging: A special issue including both human and rodent studies. | Deak T et al. | — | 2019 | → |